AbbVie
ABBV
#32
Rank
S$476.15 B
Marketcap
S$269.50
Share price
-0.18%
Change (1 day)
12.75%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): S$8.55 Billion

According to AbbVie's latest financial reports the company's current earnings are S$61.16 Billion. , an increase over its 2024 earnings that were of S$4.76 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 S$8.45 B77.53%
2024 S$4.76 B-40.54%
2023 S$8.00 B-53.62%
2022 S$17.26 B3.76%
2021 S$16.63 B282.25%
2020 S$4.35 B-59.67%
2019 S$10.79 B62.13%
2018 S$6.65 B-32.74%
2017 S$9.89 B-1.99%
2016 S$10.09 B18.65%
2015 S$8.51 B180.5%
2014 S$3.03 B-55.57%
2013 S$6.83 B-6.86%
2012 S$7.33 B56.05%
2011 S$4.69 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.56 B 60.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.87 B 371.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.64 B 37.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.07 B-75.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.54 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.29 B 45.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$18.78 B 122.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
S$12.82 B 51.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$1.02 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA